Companion Animal Diagnostic Services Market Overview

The Global Companion Animal Diagnostic Services Market is projected to reach USD 15.7 billion by 2033, from USD 8.9 billion in 2025, growing at a CAGR of 7.6% during the forecast period. The market is witnessing robust growth driven by the increasing pet ownership rates, rising expenditure on animal healthcare, and advancements in veterinary diagnostic technologies. Companion animal diagnostic services encompass a range of testing methods designed to detect diseases, monitor health conditions, and ensure timely medical intervention for pets such as dogs, cats, and horses.

The Point-of-Care (POC) segment dominated the market in 2025, accounting for a 57.8% share, owing to the increasing demand for rapid diagnostic solutions that can provide real-time results within veterinary clinics. Clinical Chemistry remains the largest testing category, as it helps assess organ function and detect metabolic disorders in animals. Dogs continue to represent the largest animal type segment due to their high global population and greater frequency of veterinary visits. Geographically, North America leads the global market, accounting for a major share in 2025, attributed to high pet ownership rates, strong veterinary infrastructure, and growing awareness of preventive healthcare.

Companion Animal Diagnostic Services Market Drivers and Opportunities

Rising pet ownership and increasing expenditure on animal healthcare

The global surge in pet adoption and humanization of animals has significantly increased the demand for high-quality veterinary diagnostic services. Across major economies such as the U.S., the U.K., Germany, and Japan, companion animals are increasingly viewed as family members, leading to heightened concern for their health and well-being. According to the American Pet Products Association (APPA), over 66% of U.S. households own a pet, with annual spending on veterinary care and diagnostics surpassing USD 38 billion in 2024. This expanding pet population has created sustained demand for early disease detection, vaccination monitoring, and wellness testing. Pet owners are increasingly opting for comprehensive diagnostic screening to ensure preventive care, detect genetic or chronic conditions, and improve treatment outcomes. Moreover, the rise in insurance coverage for companion animals in developed countries is encouraging greater use of diagnostic services. Veterinary clinics and hospitals are also investing in advanced diagnostic tools such as digital imaging, hematology analyzers, and molecular testing kits to meet growing demand. The shift from reactive to preventive veterinary healthcare is accelerating adoption across both in-clinic and laboratory-based testing environments. As a result, pet diagnostics have become an integral component of modern animal healthcare systems worldwide.

Advancements in diagnostic technologies and the growing adoption of Point-of-Care testing

Technological innovations in veterinary diagnostics are transforming the landscape of animal healthcare. The increasing availability of Point-of-Care (POC) testing solutions enables veterinarians to perform rapid and accurate diagnostics within minutes, improving clinical decision-making and patient outcomes. Portable analyzers and compact devices now allow in-house testing for conditions such as infectious diseases, metabolic disorders, and hormonal imbalances. Additionally, molecular diagnostics such as PCR (Polymerase Chain Reaction) and ELISA (Enzyme-Linked Immunosorbent Assay) tests are gaining traction for their precision in detecting pathogens and genetic abnormalities. Integration of AI-based imaging, digital pathology, and cloud-based data management systems is further enhancing diagnostic accuracy and efficiency. These advancements reduce dependency on centralized labs, minimize turnaround times, and allow for immediate treatment interventions. Leading veterinary diagnostic providers are also expanding their POC portfolios through strategic collaborations and R&D investments. For example, companies like IDEXX Laboratories and Zoetis have introduced advanced diagnostic platforms that seamlessly connect clinical data, enabling veterinarians to manage cases more effectively. As these technologies become more affordable and user-friendly, their adoption is expected to rise globally, particularly in emerging veterinary markets.

Opportunity for the Companion Animal Diagnostic Services Market

Expanding veterinary infrastructure and rising demand in emerging markets

Emerging economies, particularly in the Asia Pacific, Latin America, and Eastern Europe, present vast untapped opportunities for the companion animal diagnostic services market. Rising income levels, increasing pet ownership, and growing awareness of animal welfare are key factors fueling market expansion in these regions. Governments and private players are investing in veterinary infrastructure, including diagnostic laboratories and animal hospitals, to meet the rising demand for advanced healthcare services. Countries such as India, China, and Brazil are witnessing rapid growth in organized pet care sectors, including grooming, nutrition, and healthcare. The growing number of veterinary professionals, coupled with digital health initiatives, is creating a conducive environment for diagnostic service expansion. Furthermore, local diagnostic providers are collaborating with international players to introduce cost-effective testing solutions tailored to regional needs. In addition, mobile veterinary units, telemedicine platforms, and digital diagnostic kits are bridging accessibility gaps in rural and semi-urban areas. With expanding 4G/5G connectivity and growing digital literacy, these tools are making animal diagnostics more accessible to a wider population. The combination of expanding infrastructure and increasing pet health consciousness positions emerging markets as a key growth frontier for global veterinary diagnostic service providers over the next decade.

Companion Animal Diagnostic Services Market Scope

Companion Animal Diagnostic Services Market Report Segmentation Analysis

The global Companion Animal Diagnostic Services Market industry analysis is segmented by Testing Category, by Type, by Animal Type, and by region.

Point-of-Care (POC) segment accounted for the largest market share in the global companion animal diagnostic services market

The Point-of-Care (POC) segment held the largest share of 57.8% in 2025, owing to the increasing need for rapid diagnostic results in veterinary practices. POC testing allows veterinarians to obtain immediate results and make quick clinical decisions, significantly improving treatment outcomes. Portable analyzers for hematology, biochemistry, and immunoassays have become essential tools in small animal clinics and emergency care facilities.

Furthermore, POC diagnostics reduce the dependency on centralized laboratories, especially in rural or resource-limited areas. The integration of wireless connectivity and cloud-based reporting enables seamless data sharing between clinics and laboratories. Continuous product innovation, user-friendly interfaces, and growing affordability are further fueling adoption. The shift toward decentralized testing models is expected to sustain POC’s dominance throughout the forecast period.

The Clinical Chemistry testing category accounted for the largest market share in 2025

Clinical Chemistry dominated the global market in 2025, representing the largest testing category due to its critical role in assessing metabolic and organ-related disorders in animals. This testing helps veterinarians evaluate liver, kidney, and pancreatic functions and detect diseases such as diabetes, thyroid imbalances, and electrolyte abnormalities. The growing awareness among pet owners about early disease detection and wellness monitoring is driving the demand for such comprehensive biochemical testing.

Technological advancements have also enhanced automation, precision, and test speed in veterinary laboratories. Moreover, the integration of chemistry analyzers within in-clinic testing systems has further simplified the diagnostic process. As more companion animals undergo regular health screenings, the clinical chemistry segment will continue to hold a leading position in the global diagnostic services market.

Dogs accounted for the largest share among animal types in the global market

Dogs represented the largest animal-type segment in 2025, driven by their widespread ownership and high frequency of veterinary visits compared to other companion animals. Rising incidence of infectious and chronic diseases among dogs, such as diabetes, arthritis, and cardiovascular disorders, necessitates regular diagnostic testing. Additionally, the emotional and economic value associated with dogs prompts owners to invest heavily in preventive healthcare and diagnostic monitoring. Veterinary clinics and hospitals increasingly offer breed-specific diagnostic panels to detect genetic predispositions, ensuring tailored healthcare. The growing popularity of canine wellness programs, pet insurance, and tele-veterinary consultations further boosts demand. With dogs accounting for the largest share of the global companion animal population, this segment will continue to dominate the diagnostic services market during the forecast period.

The following segments are part of an in-depth analysis of the global Companion Animal Diagnostic Services Market:

Companion Animal Diagnostic Services Market Share Analysis by Region

The North America region is projected to hold the largest share of the global Companion Animal Diagnostic Services Market over the forecast period.

North America held the largest share of the global Companion Animal Diagnostic Services Market in 2025, driven by high pet ownership rates, advanced veterinary infrastructure, and increased healthcare expenditure on pets. The U.S. is the largest contributor in the region, home to leading players such as IDEXX Laboratories, Zoetis, and Mars Inc., who provide comprehensive diagnostic solutions across clinics, hospitals, and research centers. Moreover, pet insurance penetration and awareness of preventive care have significantly contributed to market maturity in the region.

In contrast, the Asia Pacific region is projected to register the fastest CAGR between 2025 and 2033. This growth is fueled by rising disposable incomes, urbanization, and growing pet humanization trends. Countries like India, China, and Australia are witnessing increased investments in veterinary facilities and diagnostic laboratories. The presence of emerging local diagnostic providers and collaborations with global companies are enhancing accessibility and affordability. With expanding pet care ecosystems, the Asia Pacific region is expected to emerge as a key revenue generator in the coming decade.

Companion Animal Diagnostic Services Market Competition Landscape Analysis

The global Companion Animal Diagnostic Services Market is highly competitive, featuring both established multinational corporations and regional veterinary service providers. Major players include Zoetis Services LLC, IDEXX Laboratories, Inc., Mars Inc., The Animal Medical Center, Embark Veterinary, Inc., SYNLAB, Nationwide Laboratories, IVC Evidensia, CVS Group Plc, and Greencross Vets.

Global Companion Animal Diagnostic Services Market Recent Developments News:

• In September 2024, Zoetis Inc. launched the Vetscan OptiCell, a cartridge-based hematology analyzer that uses AI technology to provide lab-quality Complete Blood Count (CBC) results at the point of care. Designed for veterinary clinics, the system offers time, cost, and space savings while maintaining diagnostic precision.

• In July 2024, EKF Diagnostics introduced the Biosen C-Line glucose and lactate analyzer, featuring a touch screen interface and enhanced connectivity via EKF Link for seamless integration with hospital IT systems. The benchtop device delivers high-precision measurements for clinical diabetes management and athletic performance monitoring.

• In February 2024, MiDOG Animal Diagnostics unveiled an All-in-One Diagnostic Test using molecular technology to rapidly identify bacterial and fungal infections, including antibiotic resistance, in multiple animal species. The test provides a faster, more comprehensive alternative to traditional methods, supporting targeted treatment in veterinary medicine.

The Global Companion Animal Diagnostic Services Market is dominated by a few large companies, such as

●        Zoetis Services LLC

●        IDEXX Laboratories, Inc.

●        Mars Inc.

●        The Animal Medical Center

●        Embark Veterinary, Inc.

●        SYNLAB

●        NationWide Laboratories

●        IVC Evidensia

●        CVS Group Plc

●        Greencross Vets Other Prominent Players